What is Inovalon?
Inovalon operates as a technology company, providing advanced cloud-based platforms that are instrumental in empowering a data-driven transformation across the healthcare ecosystem. Leveraging extensive data interconnectivity, proprietary datasets, sophisticated analytics, and deep industry expertise, Inovalon enables organizations to enhance clinical outcomes, improve quality metrics, and optimize financial performance. Its solutions cater to a broad spectrum of clients, including health plans, provider organizations, and life sciences companies, supporting approximately 500 healthcare organizations. The company's platforms are informed by a vast repository of data, encompassing insights on physicians, clinical facilities, and a significant portion of the U.S. population, facilitating a comprehensive approach to healthcare management and improvement.
How much funding has Inovalon raised?
Inovalon has raised a total of $7.9B across 2 funding rounds:
Stock Offering
$600M
Private Equity
$7.3B
Stock Issuance/Offering (2015): $600M, investors not publicly disclosed
Private Equity (2021): $7.3B led by 22C Capital, Insight Partners, Keith Dunleavy, and Nordic Capital
What's next for Inovalon?
With the infusion of major enterprise-level funding and a recent strategic investment, Inovalon is well-positioned for continued expansion and innovation. The company's focus on value-based care models aligns with current industry trends and regulatory shifts, suggesting a trajectory of sustained growth. Future developments are likely to involve further enhancement of its data analytics capabilities, broader adoption of its cloud-based platforms, and strategic partnerships aimed at deepening its impact across the healthcare value chain. This significant backing provides the resources necessary to scale operations, invest in research and development, and solidify its market leadership in transforming healthcare through technology.
See full Inovalon company page
